1Packer M,Coats AJ,Fowler MB,et al.Effect of carvedilol on survival in severe chronic heart failure.N Engl J Med,2001,344:1651-1658.
2Pitt B,Sannad F,Remme WJ,et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure.N Engl J Med,1999,341:709-717.
3Rose EA,Gelijns AC,Moskowitz AJ,et al.Long-term use of a left ventricular assist device for end-stage heart failure.N Engl J Med,2001,345:1435-1443.
4Braunschweig F,Linde C.Continuous hemodynamic monitoring in heart failure.J Cardiovasc Electrophysiol,2002,13(Suppl):S68-S72.
5Braumschweig F,Linde C,Eriksson MJ,et al.Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.Eur Heart J,2002,23:59-69.
6Podrid PJ,Fogel RI,Tordjman-Fuchs T.Arrhythmia in patients with cardiomyopathy and congestive heart failure.In:Hosenpud JD,Greenberg BH,eds.Congestive heart failure.New York:Springer-Verlag,1994.653-654.
7Goldman S,Johnson G,Cohn JN,et al.Mechanism of death in heart failure:the vasodilator-heart failure trials.Circulation,1993,87 (Suppl):Ⅵ24-Ⅵ31.
8Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.N Engl J Med,2002,346:877-883.
9Saman N,William HM,Miles JS,et al.Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure.Am Heart J,2005,150:955-960.
1[1]Pfeifer MA, Braunwald E. Ventricular remodeling after myocardial infarction:experimental observations and clinical implications. Circulation,1990,81:1161～ 1172.
2[2]Li RK, Mickle DA, Weisel RD,et al. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res,1996,78:283～ 288.
3[3]Charles EM, Robert WW, Stephen MS. Skeletal Myoblast Transplantation for Repair of Myocardial Necrosis.J Clin Invest,1996,98(11):2512～ 2523.
4[4]Donald O, Jan K, Stefano C, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001,410:701～ 705.
5[5]Mohit J, Harout D, Daniel AB,et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction.Circulation,2001,103:1920～ 1927.
8[8]Jian YM, Matthew FS, Yinke Y, et al. Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs. Ann Thorac Surg, 2002, 74:1568～ 1575.
9[9]Menasche B, Hagege AA, Scorsin M. Myoblast transplantation for heart failure. Lancet,2001,357;279～ 280.
10[10]Kehat I, Kenyagin- Karsenti D, Snir M. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest, 2001,108:407～ 414.
